Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy transactions that occurred between Sept.23-30. Deal Watch is supported by deal intelligence from Strategic Transactions.
Canadian biotech Zymeworks Inc. and Japan's Daiichi Sankyo Co. Ltd. announced a cross-cutting cancer alliance Sept. 28 that...